Filed Nov. 1, 2021

Serial No. 97102047

Examining Attorney BRENDAN D MCCAULEY

Class Psychedelic medicines for the treatment of psychiatric diseases, namely, mood disorders, depression, mood and emotional instability disorders; psychedelic medicines for the treatment of addiction disorders, namely, alcohol abuse, drug abuse, eating disorders, gambling addiction and sex addiction; psychedelic medicines for the treatment of anxiety disorders, namely, social anxiety, generalized anxiety and panic attack disorder; psychedelic medicines for the treatment of psychological trauma, namely, post-traumatic stress disorder, occupational stress injury, bullying, emotional trauma, physical trauma, work trauma, family violence and grief; psychedelic medicines for the treatment of physical trauma, namely, post-burn injury, post-spinal-cord injury, adult post-amputation, post-brain injury and post-stroke; psychedelic medicines for the treatment of chronic pain, namely, migraines, chronic back pain and chronic arthritis; psychedelic medicines for the treatment of cognitive diseases, namely, cognitive deterioration, early dementia and age-associated memory impairment; psychedelic medicines for the treatment of neuropsychiatric disorders, namely, adult fetal alcohol spectrum disorder, adult attention deficit disorder, adult autism, post-stroke symptoms, multiple sclerosis and Parkinson's disease; psychedelic medicines for the treatment of sleep related disorders, namely, chronic fatigue syndrome, fatigue and insomnia; psychedelic medicines for the treatment of mental health problems experienced by indigenous and other marginalized communities; psychedelic medicines for the treatment of covid-19 symptoms and syndromes; 005; 006; 018; 044; 046; 051; 052; 021; 023; 026; 036; 038; 046; 001; 046; 100; 101; 102; 100; 101; 107; 100; 101; 100; 101

Case Type Trademark Service mark